World Orphan Drug Congress USA 2017

 

 

THE GLOBAL ORPHAN DRUG
CONFERENCE AND EXPO

 

19 - 21 April 2017

1,000  High-level attendees

50+ Sponsors and exhibitors

150+  Expert Speakers

Possibilities:  UNLIMITED

WHAT IS THE WORLD ORPHAN DRUG CONGRESS USA?  


3 Conferences. 3 Days. 1 Event.

At the World Orphan Drug Congress USA in April 2017, we are bringing together more than 150 elite speakers to educate and inspire our 1,000 attendees from big pharma, biotech, payers, patient groups, academics and government bodies. In 2017, World Orphan Drug Congress USA is bringing together the worlds of Scientific Innovation and Commercialization, with 2 tracks in the main conference. 

By exploring trends in Digital Health, Biosimilars, Gene Therapy, and more, we will uncover the next scientific breakthrough. Examinations of Mergers, Commercialization, Marketing and the Regional Markets will provide insight into this billion-dollar business. That's not all with Rare Disease Advocacy World and Pitch and Partner 2017, there are 4 tracks of content for you and your team to enjoy. 

Enjoy discussions on: 

FUTURE OF ORPHAN DRUGS

PRICING & REIMBURSEMENT

APPROVAL & ACCESS

M&A AND COMMERCIALIZATION

PATIENT-CENTRIC RESEARCH

REAL-WORLD EVIDENCE

MARKETING & COMPETITIVENESS

GENE THERAPY

SCIENTIFIC INNOVATION

REGIONAL MARKET ANALYSIS

BIOSIMILARS

ROUNDTABLES

Click on these logos for more information on: 

Rare Disease Advocacy World USA at World Orphan Drug Congress

Pitch and Partner at World Orphan Drug Congress USA 2017

 

Download the World Orphan Drug Congress USA 2017 prospectus

The largest global orphan drug industry event

The World Orphan Drug Congress USA is a place where innovation and expertise is showcased, solutions are found and learning is done.

 

If you offer a solution or product in the orphan drug space, the World Orphan Drug Congress USA is definitely the right place to do this.

 

DOWNLOAD BROCHURE


 

2017 SPEAKERS INCLUDE

 

  • Karen Aiach at World Orphan Drug Congress USA 2017
    Karen Aiach
    Founder and Chief Executive Officer
    Lysogene
    Einar Andreassen at World Orphan Drug Congress USA 2017
    Einar Andreassen
    Senior Adviser
    Norwegian Medicines Agency
  • Donna Armentano at World Orphan Drug Congress USA 2017
    Donna Armentano
    Global Head of Gene Therapy
    Pfizer, Inc
    Alison Bateman House at World Orphan Drug Congress USA 2017
    Alison Bateman House
    Postdoctoral Fellow, Division of Medical Ethics,
    New York University Langone Medical Center
  • Ms Soraya Bekkali at World Orphan Drug Congress USA 2017
    Ms Soraya Bekkali
    Senior Vice President and Chief Medical Officer
    Lysogene
    Stella Blackburn at World Orphan Drug Congress USA 2017
    Stella Blackburn
    VP, Global Head of Risk Management
    QuintilesIMS
  • Max Bronstein at World Orphan Drug Congress USA 2017
    Max Bronstein
    Senior Director, Public and Government Relations
    EveryLife Foundation for Rare Diseases
    Angela Chaves at World Orphan Drug Congress USA 2017
    Angela Chaves
    President
    FEDERACION COLOMBIANA DE ENFERMEDADES RARAS
  • Leah Christl at World Orphan Drug Congress USA 2017
    Leah Christl
    AD,Therapeutic Biologics & Biosimilars
    F.D.A.
    Margaret Collins at World Orphan Drug Congress USA 2017
    Margaret Collins
    Professor of Pediatrics
    Cincinnati Childrens Hospital
  • Francesca Cook at World Orphan Drug Congress USA 2017
    Francesca Cook
    Director, Pricing and Market Access
    RegenxBio
    Gregory Daniel at World Orphan Drug Congress USA 2017
    Gregory Daniel
    Deputy Director
    Duke University
  • Peter Dehnel at World Orphan Drug Congress USA 2017
    Peter Dehnel
    Medical Director
    Blue Cross and Blue Shield of Minnesota
    Keith DeMatteo at World Orphan Drug Congress USA 2017
    Keith DeMatteo
    Director, Global Procurement
    Bristol Myers Squibb
  • Kelly Du Plessis at World Orphan Drug Congress USA 2017
    Kelly Du Plessis
    Chief Executive Officer
    Rare Disease Society of South Africa
    Glyn Edwards at World Orphan Drug Congress USA 2017
    Glyn Edwards
    Chief Executive Officer
    Summit Therapeutics
  • Mary Frances Harmon at World Orphan Drug Congress USA 2017
    Mary Frances Harmon
    Head of Global Patient Advocacy
    PTC Therapeutics
    Pat Furlong at World Orphan Drug Congress USA 2017
    Pat Furlong
    Founding President and Chief Executive Officer
    Parent Project Muscular Dystrophy
  • Vignesh Ganapathy at World Orphan Drug Congress USA 2017
    Vignesh Ganapathy
    AD of Advocacy & Government Relations
    EveryLife Foundation for Rare Diseases
    Chris Garabedian at World Orphan Drug Congress USA 2017
    Chris Garabedian
    Former President and Chief Executive Officer
    Sarepta Therapeutics
  • Jayne Gershkowitz at World Orphan Drug Congress USA 2017
    Jayne Gershkowitz
    Senior Vice President and Chief Patient Advocate
    Amicus Therapeutics Inc
    Jonathan Goldsmith at World Orphan Drug Congress USA 2017
    Jonathan Goldsmith
    Associate Director Rare Diseases Program
    Food And Drug Administration
  • Rashmi Gopal-Srivastava at World Orphan Drug Congress USA 2017
    Rashmi Gopal-Srivastava
    Dir, Extramural Research Program, Office Rare Diseases
    National Institutes of Health
    Scott Gray at World Orphan Drug Congress USA 2017
    Scott Gray
    Chief Executive Officer
    Clincierge
  • James Greenwood at World Orphan Drug Congress USA 2017
    James Greenwood
    Chief Executive Officer
    Biotechnology Industry Organization
    Colin Hayward at World Orphan Drug Congress USA 2017
    Colin Hayward
    Chief Medical Officer
    Premier Research
  • Jonathan Heller at World Orphan Drug Congress USA 2017
    Jonathan Heller
    Global Head, External R&D Innovation,Rare Diseases
    Pfizer, Inc
    Claudia Hirawat at World Orphan Drug Congress USA 2017
    Claudia Hirawat
    Chair
    EURORDIS International Circle of Ambassadors
  • Kenneth Hobby at World Orphan Drug Congress USA 2017
    Kenneth Hobby
    President
    Cure SMA
    Angus Hogg at World Orphan Drug Congress USA 2017
    Angus Hogg
    Vice President Hunters (MPSII) Franchise
    Shire Pharmaceuticals Ltd
  • Kaykay holcombe at World Orphan Drug Congress USA 2017
    Kaykay holcombe
    Senior Vice President for Science Policy
    Biotechnology Industry Organization (BIO)
    Wills Hughes-Wilson at World Orphan Drug Congress USA 2017
    Wills Hughes-Wilson
    Senior Vice President, Chief Patient Access Officer
    Sobi
  • Dr Cynthia Jackson at World Orphan Drug Congress USA 2017
    Dr Cynthia Jackson
    VP & Head, Pediatric & Rare Disease Cnrts of Excellence
    QuintilesIMS
    Donald Johns at World Orphan Drug Congress USA 2017
    Donald Johns
    VP, Head of ALS and SMA Clinical Development
    Biogen
  • Matt Kapusta at World Orphan Drug Congress USA 2017
    Matt Kapusta
    Chief Executive Officer
    uniQure
    Petra Kaufmann at World Orphan Drug Congress USA 2017
    Petra Kaufmann
    Director, Office of Rare Diseases Research
    National Institutes of Health
  • Sven Kili at World Orphan Drug Congress USA 2017
    Sven Kili
    Vice President and Head of Gene Therapy Development
    GSK
    Yann Le Cam at World Orphan Drug Congress USA 2017
    Yann Le Cam
    Chief Executive Officer
    EURORDIS
  • Nadea Leavitt at World Orphan Drug Congress USA 2017
    Nadea Leavitt
    Engagement Mgr, Predictive Analytics, RW Insights
    QuintilesIMS
    Nick Leschly at World Orphan Drug Congress USA 2017
    Nick Leschly
    President and Chief Executive Officer
    bluebird bio
  • Terrie Livingston at World Orphan Drug Congress USA 2017
    Terrie Livingston
    Senior Director, US Medical
    Biogen
    Aoife M Brennan at World Orphan Drug Congress USA 2017
    Aoife M Brennan
    Chief Medical Officer
    Synlogic Therapeutics
  • Jeffrey D. Marrazzo at World Orphan Drug Congress USA 2017
    Jeffrey D. Marrazzo
    Co Founder and Chief Executive Officer
    Spark Therapeutics
    Howard Mayer at World Orphan Drug Congress USA 2017
    Howard Mayer
    SVP & Head of Global Clinical Development
    Shire Pharmaceuticals Inc
  • Andrew McFayden at World Orphan Drug Congress USA 2017
    Andrew McFayden
    Executive Director
    The Isaac Foundation
    Paul Melmeyer at World Orphan Drug Congress USA 2017
    Paul Melmeyer
    Associate Director of Public Policy
    National Organization for Rare Disorders
  • Christopher Missling at World Orphan Drug Congress USA 2017
    Christopher Missling
    President and Chief Executive Officer
    Anavex Life Sciences
    Kenneth Moch at World Orphan Drug Congress USA 2017
    Kenneth Moch
    President & CEO, Cognition Therapeutics; Former President & CEO
    Chimerix
  • Richard Moscicki at World Orphan Drug Congress USA 2017
    Richard Moscicki
    Deputy Director for Science Operations, CDER
    FDA
    Michael Murphy at World Orphan Drug Congress USA 2017
    Michael Murphy
    Chief Medical & Scientific Officer
    Worldwide Clinical Trials
  • Francois Nader at World Orphan Drug Congress USA 2017
    Francois Nader
    Former President & CEO, NPS, Board Chairman
    Acceleron Pharma
    Yukiko Nishimura at World Orphan Drug Congress USA 2017
    Yukiko Nishimura
    Chief Secretariat of International Relations
    Japan Patients Association, ASrid
  • Letitia O'dwyer at World Orphan Drug Congress USA 2017
    Letitia O'dwyer
    Chief Executive Officer
    New Zealand Organisation For Rare Disorders
    Luca Pani at World Orphan Drug Congress USA 2017
    Luca Pani
    Former Gen Director AIFA, CHMP and SAWP Member
    European Medicines Agency
  • Eric Pauwels at World Orphan Drug Congress USA 2017
    Eric Pauwels
    SVP & General Manager, Americas
    PTC Therapeutics
    Edmund Pezalla at World Orphan Drug Congress USA 2017
    Edmund Pezalla
    Fomer VP Pharmaceutical Policy and Strategy
    Aetna
  • Andreas Pleil at World Orphan Drug Congress USA 2017
    Andreas Pleil
    Sr Dr, Team Lead, Outcomes & Evidence Hematology
    Pfizer Inc
    Sy Pretorius at World Orphan Drug Congress USA 2017
    Sy Pretorius
    SVP and Chief Scientific Officer
    PAREXEL International
  • Harsha Rajasimha at World Orphan Drug Congress USA 2017
    Harsha Rajasimha
    Co Founder
    Organization for Rare Diseases India
    Gayatri Rao JD., MD, at World Orphan Drug Congress USA 2017
    Gayatri Rao JD., MD,
    Director, Orphan Products Development
    FDA
  • Scott Rocklage at World Orphan Drug Congress USA 2017
    Scott Rocklage
    Frmer CEO, Epirus Biosciences, Partner
    5AM Ventures
    Mark Rothera at World Orphan Drug Congress USA 2017
    Mark Rothera
    Chief Commercial Officer
    PTC Therapeutics
  • Peter Saltonstall at World Orphan Drug Congress USA 2017
    Peter Saltonstall
    CEO
    National Organization For Rare Disorders
    Scott Schliebner at World Orphan Drug Congress USA 2017
    Scott Schliebner
    VP, Rare Diseases & Scientific Affairs
    PRA Health Sciences
  • Ana Maria Serrato Navas at World Orphan Drug Congress USA 2017
    Ana Maria Serrato Navas
    Country Manager, Colombia
    Aegerion Pharmaceuticals
    Thomas Sproat at World Orphan Drug Congress USA 2017
    Thomas Sproat
    Senior Vice President, Scientific Services
    ClinicalMind
  • Mary Szela at World Orphan Drug Congress USA 2017
    Mary Szela
    Chief Executive Officer
    Aegerion Pharmaceuticals
    Timothy Walbert at World Orphan Drug Congress USA 2017
    Timothy Walbert
    Chairman, President, and Chief Executive Officer
    Horizon Pharma
  • Diane White at World Orphan Drug Congress USA 2017
    Diane White
    Assoc. Dir Development Sciences
    Biomarin
    Barbara Wuebbels at World Orphan Drug Congress USA 2017
    Barbara Wuebbels
    Vice President of Patient Advocacy
    Audentes Therapeutics
  • Andrea Chiesi at World Orphan Drug Congress USA 2017
    Andrea Chiesi
    Director of R&D and Portfolio Management
    Chiesi
    Hazel Gorham at World Orphan Drug Congress USA 2017
    Hazel Gorham
    Director of Biosimilars Development
    P.R.A. Health Sciences
  • Valerie Duquet at World Orphan Drug Congress USA 2017
    Valerie Duquet
    Clinical Team Manager
    PRA Health Sciences
    Birgitte Volck at World Orphan Drug Congress USA 2017
    Birgitte Volck
    Senior Vice President, Head of R&D Rare Diseases
    GSK
  • Eric Gascho at World Orphan Drug Congress USA 2017
    Eric Gascho
    Vice President of Government Affairs
    National Health Council
    Deborah Geraghty at World Orphan Drug Congress USA 2017
    Deborah Geraghty
    Head of Commercial and Portfolio Strategy
    Dimension Therapeutics
  • Michael Goettler at World Orphan Drug Congress USA 2017
    Michael Goettler
    Global President
    Pfizer Rare Disease
    Marc Martinell at World Orphan Drug Congress USA 2017
    Marc Martinell
    Chief Executive Officer
    Minoryx Therapeutics
  • Nancy Parsons at World Orphan Drug Congress USA 2017
    Nancy Parsons
    VP Commercial Operations, Pharma Products
    SigmaTau Pharmaceuticals
    Katrine Bosley at World Orphan Drug Congress USA 2017
    Katrine Bosley
    Chief Executive Officer
    Editas Medicine
  • Professor Matthias Schönermark at World Orphan Drug Congress USA 2017
    Professor Matthias Schönermark
    Chief Executive Officer
    SKC Beratungsgesellschaft
    Dale Bodian at World Orphan Drug Congress USA 2017
    Dale Bodian
    Manager Bioinformatics Scientist
    Inova Translational Medicine Institute
  • Murray Brilliant at World Orphan Drug Congress USA 2017
    Murray Brilliant
    Senior Research Scientist and Center Director
    Marshfield Clinic Research Foundation
    Anna Bucsics at World Orphan Drug Congress USA 2017
    Anna Bucsics
    External Lecturer, MoCA board member
    University of Vienna
  • Andrea Califano at World Orphan Drug Congress USA 2017
    Andrea Califano
    Chair, Systems Biology Department
    Columbia University U.S.A.
    Invited: John Coster at World Orphan Drug Congress USA 2017
    Invited: John Coster
    Director, Division of Pharmacy
    Center for Medicare and Medicaid Services
  • Mark de Boer at World Orphan Drug Congress USA 2017
    Mark de Boer
    Chief Executive Officer
    FF Pharma
    Florian Eichler at World Orphan Drug Congress USA 2017
    Florian Eichler
    Associate Professor of Neurology
    Massachusetts General Hospital
  • David Fajgenbaum at World Orphan Drug Congress USA 2017
    David Fajgenbaum
    Assistant Professor of Medicine
    Upenn Center For Orphan Disease Research and Therapy
    Thomas J Farrell at World Orphan Drug Congress USA 2017
    Thomas J Farrell
    Chief Executive Officer
    Bellicum Pharmaceuticals, Inc.
  • William Gahl at World Orphan Drug Congress USA 2017
    William Gahl
    Clinical Director
    Director of the N.I.H. Undiagnosed Diseases Program
    Edmund Jessop at World Orphan Drug Congress USA 2017
    Edmund Jessop
    Medical Adviser
    National Health Service
  • Takashi K Kishimoto at World Orphan Drug Congress USA 2017
    Takashi K Kishimoto
    Chief Scientific Officer
    Selecta Biosciences Inc
    Jennifer Kwon at World Orphan Drug Congress USA 2017
    Jennifer Kwon
    Associate Professor of Neurology and Pediatrics
    University of Rochester
  • Jeff Myers at World Orphan Drug Congress USA 2017
    Jeff Myers
    CEO
    Medicaid Health Plans of America
    Nikhil Nair at World Orphan Drug Congress USA 2017
    Nikhil Nair
    Assist Professor, Dept of Chemical and Biological Engineering
    Tufts University
  • Romina Ortiz at World Orphan Drug Congress USA 2017
    Romina Ortiz
    VP Policy & Patient Advocacy
    Rare Genomics Institute
    Detlev Parow at World Orphan Drug Congress USA 2017
    Detlev Parow
    Head, Care Management Development
    D.A.K.
  • Adam Resnick at World Orphan Drug Congress USA 2017
    Adam Resnick
    Director, Ctr for Data Driven Discovery in Biomedicine
    The Children's Hospital of Philadelphia
    Samuel Seward at World Orphan Drug Congress USA 2017
    Samuel Seward
    Site Chair, Department of Medicine
    Mount Sinai Hospital
  • James Wilson at World Orphan Drug Congress USA 2017
    James Wilson
    Director, Orphan Disease Center
    University of Pennsylvania
    Jeff Ceitlin at World Orphan Drug Congress USA 2017
    Jeff Ceitlin
    Chief Commercial Officer
    HVH Patient Precision Analytics
  • Mr Johan Heylen at World Orphan Drug Congress USA 2017
    Mr Johan Heylen
    Chief Commercial Officer
    Ablynx
    Mr John Leonard at World Orphan Drug Congress USA 2017
    Mr John Leonard
    CMO
    Intellia Therapeutics Inc
  • Ethan Oren Perlstein at World Orphan Drug Congress USA 2017
    Ethan Oren Perlstein
    Chief Executive Officer
    Perlstein Labs
    Meriem Bouslouk at World Orphan Drug Congress USA 2017
    Meriem Bouslouk
    Officer, Innovation Committee
    Federal Joint Committee
  • Jerry R. Mendell at World Orphan Drug Congress USA 2017
    Jerry R. Mendell
    Director, Center for Gene Therapy
    Nationwide Children's Hospital
    Trevor Richter at World Orphan Drug Congress USA 2017
    Trevor Richter
    Director, Common Drug Review and Optimal Use
    C.A.D.T.H.

 

SEE ALL 2017 SPEAKERS

WHO ATTENDS?

Here's a glimpse of who attends World Orphan Drug Congress USA

 

AccessPharmaCon,LLC Aegerion Pharmaceuticals  Aetna Pharmacy Management  Alexion Pharmaceuticals  Andarix Pharmaceuticals  ArmaGen Technologies, Inc.  Ashfield Healthcare   Asklepion Pharmaceuticals LLC  Ax-S Pharma  B.D.C. Venture Capital  BioBlast Pharma Ltd  Biomarin Pharmaceutical Inc.  BioPontis Alliance for Rare Disease Brace Pharma Capital   Brazilian Federal Council of Medicine  Bristol-Myers Squibb  CatalentPharma Solutions   CatalystPharmaceutical Partners  CDER FDA  Clear Pharma  Clementia Pharmaceuticals Inc.   Clinuvel Pharmaceuticals Ltd  Dicerna Pharmaceuticals  DrugDev  EvaluatePharma Ltd   Genoa Pharmaceuticals   Genpharm  GenSight Biologics  Genzyme Corp  Giddi Pharma Co., Ltd.   Idera Pharmeceuticals  IDIS Pharma   Iptechex Pharmalicensing  Jazz Pharmaceuticals, Inc  Juice Pharma Worldwide   KBI Biopharma Inc   Lumos Pharma   M3 Pharma  Marathon Pharmaceuticals LLC   Marinus Pharmaceuticals  Momenta Pharmaceuticals Inc  Opsona Therapeutics Ltd  Optio Biopharma Solutions LLC  Orpharma  Pfizer, Inc  Pharmaceutics International In  Pharmaessentia Corp   Pharnext   Portola Pharmaceuticals , Inc.  Provectus PharmaceuticalsInc   QuayPharma  Quintiles Inc  Raptor Pharmaceuticals Corp  Reata Pharmaceuticals   Recordati S.p.A  Recursion Pharmaceuticals  Retrophin   Sanofi   Savara Pharmaceuticals  Seattle Children's Research Institute   Shire Pharmaceuticals Inc  Taiba Pharma LLC Teva  Threshold Pharmaceuticals Inc   Tolero Pharmaceuticals   Ultragenyx Pharmaceutical Inc.  Valley Fever Solutions   Vanda Pharmaceuticals Inc   Vertex Pharmaceuticals 

 

FIND OUT MORE

GET YOUR PASS NOW

Choose your package

Prices increase after 6th January – book now to get these prices

 

2 DAY CONFERENCE


Individual Pass

USD $2,380

BOOK NOW

 

Group Booking of 3 or more

USD $2,025

BOOK NOW

3 DAY CONFERENCE


Individual Pass

USD $2,910

BOOK NOW

 

Group Booking of 3 or more

USD $2,470

BOOK NOW

World Orphan Drug Congress USAWorld Orphan Drug Congress USAWorld Orphan Drug Congress USAWorld Orphan Drug Congress USAWorld Orphan Drug Congress USAWorld Orphan Drug Congress USAWorld Orphan Drug Congress USAWorld Orphan Drug Congress USAWorld Orphan Drug Congress USAWorld Orphan Drug Congress USAWorld Orphan Drug Congress USAWorld Orphan Drug Congress USA

Sponsor World Orphan Drug Congress USA

Get Involved

Your customers are here continuously looking for new strategies and technologies to expedite orphan drugs to patients.

 

If you offer a solution or product in the orphan drug space, then you need to be here

 

DOWNLOAD PROSPECTUS


 

OUR SPONSORS & EXHIBITORS

 

  • Platinum Sponsor

    Premier Research at World Orphan Drug Congress USA 2017

    Platinum Sponsor

    Sigma-Tau Pharmaceuticals at World Orphan Drug Congress USA 2017

    Platinum Sponsor

    PTC Therapeutics at World Orphan Drug Congress USA 2017
  • Gold Sponsor

    AmerisourceBergen at World Orphan Drug Congress USA 2017

    Gold Sponsor

    Cello Health at World Orphan Drug Congress USA 2017

    Gold Sponsor

    GlaxoSmithKline at World Orphan Drug Congress USA 2017
  • Gold Sponsor

    Parexel at World Orphan Drug Congress USA 2017

    Silver Sponsor

    Clincierge at World Orphan Drug Congress USA 2017

    Silver Sponsor

    ClinicalMind at World Orphan Drug Congress USA 2017
  • Silver Sponsor

    HVH Patient Precision Analytics at World Orphan Drug Congress USA 2017

    Silver Sponsor

    onevoice at World Orphan Drug Congress USA 2017

    Silver Sponsor

    Pfizer at World Orphan Drug Congress USA 2017
  • Silver Sponsor

    PPD at World Orphan Drug Congress USA 2017

    Silver Sponsor

    PRA Health Sciences at World Orphan Drug Congress USA 2017

    Silver Sponsor

    SKC Beratungsgesellschaft at World Orphan Drug Congress USA 2017
  • Silver Sponsor

    QuintilesIMS at World Orphan Drug Congress USA 2017

    Silver Sponsor

    WEP Clinical at World Orphan Drug Congress USA 2017

    Bronze Sponsor

    Covance at World Orphan Drug Congress USA 2017
  • Bronze Sponsor

    Lapidus Data at World Orphan Drug Congress USA 2017

    Bronze Sponsor

    Marken at World Orphan Drug Congress USA 2017

    Bronze Sponsor

    McKesson Canada at World Orphan Drug Congress USA 2017
  • Bronze Sponsor

    Medicom Innovation Partner a/s at World Orphan Drug Congress USA 2017

    Bronze Sponsor

    MME at World Orphan Drug Congress USA 2017

    Bronze Sponsor

    Worldwide Clinical Trials at World Orphan Drug Congress USA 2017
  • Associate Sponsor

    BluePrint Orphan at World Orphan Drug Congress USA 2017

    Exhibitor

    Axiom Real-Time Metrics Inc at World Orphan Drug Congress USA 2017

    Exhibitor

    SGS at World Orphan Drug Congress USA 2017
  • Exhibitor

    Trial Runners at World Orphan Drug Congress USA 2017

    Exhibitor

    AnovaFill at World Orphan Drug Congress USA 2017

    Exhibitor

    APL at World Orphan Drug Congress USA 2017
  • Exhibitor

    Cardinal Health at World Orphan Drug Congress USA 2017

    Exhibitor

    Clinart MENA at World Orphan Drug Congress USA 2017

    Exhibitor

    CORAM Clinical Trials at World Orphan Drug Congress USA 2017
  • Exhibitor

    Ergomed at World Orphan Drug Congress USA 2017

    Exhibitor

    Euromed srl at World Orphan Drug Congress USA 2017

    Exhibitor

    Illingworth Research Ltd at World Orphan Drug Congress USA 2017
  • Exhibitor

    INC Research at World Orphan Drug Congress USA 2017

    Exhibitor

    Omnicare Inc at World Orphan Drug Congress USA 2017

    Exhibitor

    Paragon Enterprises Inc at World Orphan Drug Congress USA 2017
  • Exhibitor

    Pharmaceutics International at World Orphan Drug Congress USA 2017

    Exhibitor

    PSR-Agility at World Orphan Drug Congress USA 2017

    Exhibitor

    Rare Patient Voice, LLC at World Orphan Drug Congress USA 2017
 

JOIN THEM

Sign up for event updates

Enter your email address

Stay connected

 

FacebookFacebook

TwitterTwitter

You TubeYou Tube

FlickrFlickr